HIV: Infection and Treatment

Dear Colleagues,

Immunodeficiency Syndrome (AIDS) is caused by the Human Immunodeficiency Virus (HIV). HIV is transmitted through unprotected sexual contact, blood exposure and from mother to child during pregnancy, birth or breastfeeding. It remains a critical global public health challenge, particularly in regions with limited access to prevention, testing and treatment services.

Currently, HIV is managed with antiretroviral therapy (ART), a combination of drugs that suppresses viral replication. Modern ART has dramatically changed the life expectancy of people living with HIV. Previous treatment regimens were highly complex with numerous side effects, requiring the intake of large numbers of tablets multiple times a day. Nowadays, ART is highly effective and well-tolerated, allowing PWH to achieve an undetectable viral load, maintain normal life expectancy and prevent transmission to others. In the future, HIV care is expected to advance further. Research is focused on long-acting therapies requiring dosing every few months, improving adherence and quality of life.

This Special Issue aims to provide a collection of articles that showcase the current issues in the research of HIV. As the Guest Editor of this Special Issue, I invite you to submit research articles, review articles and communications related to HIV infection and HIV treatment in its past, present and future.

We look forward to receiving your contributions.

Dr. Layla Pagnucco
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.